Angina Pectoris — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for angina pectoris. 10 active patents protecting 3 drugs from 3+ originators. First major cliff: 2026. Daily refresh.

3
Approved drugs
10
Active US patents
60/100
Avg vulnerability
—
Annual revenue covered

Originators in Angina Pectoris

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Pfizer 5 patents Menarini Intl 4 patents Amgen 1 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating angina pectoris. Each bar = one year. Y-axis scaled to peak year (5 patents).

1
26
5
37
4
38

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Lipitor
Atorvastatin Calcium
 Pfizer 5 61 — 2037-06-07
Ranexa
RANOLAZINE
 Menarini Intl 4 51 — 2038-01-24
Corlanor
IVABRADINE
 Amgen 1 69 — 2026-12-12

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
7867996 Corlanor method of use 80 2026-12-12
11925704 Lipitor method of use 75 2037-06-07
11654106 Lipitor method of use 70 2037-06-07
12370136 Lipitor formulation 55 2037-06-07
12168069 Lipitor formulation 55 2037-06-07
12161761 Ranexa formulation 55 2038-01-24
11369567 Lipitor formulation 50 2037-06-07
11510878 Ranexa formulation 50 2038-01-24
10898444 Ranexa formulation 50 2038-01-24
11510878 Ranexa formulation 50 2038-01-24

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
11510878 Ranexa formulation 50 2038-01-24
11510878 Ranexa formulation 50 2038-01-24
10898444 Ranexa formulation 50 2038-01-24
11369567 Lipitor formulation 50 2037-06-07
12161761 Ranexa formulation 55 2038-01-24
12168069 Lipitor formulation 55 2037-06-07
12370136 Lipitor formulation 55 2037-06-07
11654106 Lipitor method of use 70 2037-06-07
11925704 Lipitor method of use 75 2037-06-07
7867996 Corlanor method of use 80 2026-12-12

Related